Download presentation
Presentation is loading. Please wait.
Published byMarilynn Payne Modified over 6 years ago
1
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI) C. Michael Gibson, MS, MD, Roxana Mehran, MD, Christoph Bode, MD, Johnathan Halperin, MD, Freek Verheugt, MD, Peter Wildgoose, PhD, Martin van Eickels, MD, Gregory Y.H. Lip, MD, Marc Cohen, MD, Steen Husted, MD, Eric Peterson, MD, Keith Fox, MD American Heart Journal Volume 169, Issue 4, Pages e5 (April 2015) DOI: /j.ahj Copyright © 2014 Elsevier Inc. Terms and Conditions
2
Figure Study design of PIONEER AF-PCI.
American Heart Journal , e5DOI: ( /j.ahj ) Copyright © 2014 Elsevier Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.